Which of the following are common LABAs used in pulmonary disease?

Long-acting beta-agonists (LABAs) are bronchodilators that are primarily used in the management of chronic obstructive pulmonary disease (COPD) and asthma. They work by relaxing the muscles of the airways, leading to prolonged bronchodilation, which helps ease breathing over a longer duration compared to short-acting bronchodilators.

The common LABAs include formoterol, salmeterol, olodaterol, and vilanterol, all of which are specifically formulated to provide effects that last 12 hours or more. These medications are often used in combination with inhaled corticosteroids for improved asthma control or as monotherapy in COPD management.

The other options listed include medications that do not fit the definition of LABAs. Albuterol and levalbuterol are short-acting beta-agonists (SABAs), used for quick relief of acute asthma symptoms. Ipratropium and tiotropium are anticholinergic medications, not beta-agonists, and are used for their bronchodilator effects but do not fall under the LABA category. Salmeterol is indeed a LABA, but it is only one part of the broader category represented by the correct answer.